Cardiogenic Shock Complicating Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention Supported by Impella: Implications of Advanced Age and Refractory Shock on Outcomes.

ABSTRACT: With percutaneous left ventricular mechanical circulatory support devices becoming increasingly available for patients with cardiogenic shock due to acute myocardial infarction and the lack of a clear mortality benefit to date, identifying optimal candidates for this technology is crucial. We studied the effectiveness of Impella Cardiac Pow (Abiomed, Danvers, MA) in various stages of cardiogenic shock and elderly cohorts.

Design

Retrospective review.

Setting

Data were collected for patients at a single community hospital between January 1, 2018, and December 31, 2019.

Subjects

Thirty-one consecutive adult patients with cardiogenic shock due to acute myocardial infarction who received Impella Cardiac Pow support. Shock stages were defined by the Society for Cardiovascul

SUBMITTER: Boshara A 

PROVIDER: S-EPMC8202667 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature